Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
PaperCitations, authors & open-access status
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,636 citations, 2014 year and bronze oa status.
1,636
Citations
2014
Year
bronze
OA Status